Jackwood D J, Sreedevi B, LeFever L J, Sommer-Wagner S E
Food Animal Health Research Program, Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center, The Ohio State University, 1680 Madison Avenue, Wooster, OH 44691, USA.
Virology. 2008 Jul 20;377(1):110-6. doi: 10.1016/j.virol.2008.04.018. Epub 2008 May 27.
Three classic IBDV strains were previously isolated from commercial layer chicken flocks and shown to be phylogenetically related to vaccine strains but pathogenic in susceptible chickens. In this study, their viral genomes were sequenced and compared to sequences of vaccines being used in those flocks. The vaccine strains examined were sequenced directly from the manufacturer and had identical genome segment B sequences. Compared to these vaccines, the GA-1, H-30 and CS-2-35 isolates each had one silent mutation in the gene that encodes VP1. Compared to the two vaccines used at the time CS-2-35 was isolated, the segment A sequence of CS-2-35 contained numerous nucleotide and amino acid mutations suggesting the CS-2-35 virus was not closely related to these vaccines. This virus however did have amino acid mutations in VP2 that are reported to be necessary for replication in cell culture and lacked two of the three amino acid mutations previously shown to be necessary for virulence. These data suggest that CS-2-35 was a descendant from an attenuated strain of IBDV. When the segment A genomic sequences of the GA-1 and H-30 viruses were compared to the vaccines being used in those flocks they were most closely related to the attenuated D78 vaccine strain. In genome segment A, three nucleotide mutations in GA-1 and four in H-30 were observed compared to the D78 classic vaccine. These nucleotide mutations caused one amino acid (H253N) change in the GA-1 virus and two amino acids (H253Q and G259D) were different in the H-30 virus. In addition, both the GA-1 and H-30 viruses had the amino acid G76 in VP2 that appears to be unique to the vaccine D78. The data suggest that GA-1 and H-30 are genetically related and have a common ancestor even though they were isolated from geographically distant flocks. The evidence also suggests that GA-1, H-30 and CS-2-35 could be reversions from attenuated vaccine viruses or by coincidence genetically resemble classic IBDV vaccines. It should be noted that some of the classic virus vaccines were not being used according to the manufacturer's recommendations at the time the GA-1, H-30 and CS-2-35 strains were isolated. Together, the molecular and pathogenicity data indicate that a single amino acid mutation from Histidine (H) to Glutamine (Q) or Asparagine (N) at position 253 in VP2 will markedly increase the virulence of an attenuated IBDV.
三种经典的传染性法氏囊病病毒(IBDV)毒株先前从商品蛋鸡群中分离出来,显示在系统发育上与疫苗毒株相关,但对易感鸡具有致病性。在本研究中,对它们的病毒基因组进行了测序,并与这些鸡群中使用的疫苗序列进行了比较。所检测的疫苗毒株直接从制造商处测序,其基因组片段B序列相同。与这些疫苗相比,GA - 1、H - 30和CS - 2 - 35分离株在编码VP1的基因中各有一个沉默突变。与分离出CS - 2 - 35时使用的两种疫苗相比,CS - 2 - 35的片段A序列包含许多核苷酸和氨基酸突变,表明CS - 2 - 35病毒与这些疫苗关系不密切。然而,这种病毒在VP2中有氨基酸突变,据报道这些突变是在细胞培养中复制所必需的,并且缺少先前显示对毒力必需的三个氨基酸突变中的两个。这些数据表明CS - 2 - 35是IBDV减毒株的后代。当将GA - 1和H - 30病毒的片段A基因组序列与这些鸡群中使用的疫苗进行比较时,它们与减毒的D78疫苗毒株关系最密切。在基因组片段A中,与D78经典疫苗相比,GA - 1中有三个核苷酸突变,H - 30中有四个核苷酸突变。这些核苷酸突变导致GA - 1病毒中有一个氨基酸(H253N)变化,H - 30病毒中有两个氨基酸(H253Q和G259D)不同。此外,GA - 1和H - 30病毒在VP2中都有氨基酸G76,这似乎是疫苗D78所特有的。数据表明,GA - 1和H - 30在遗传上相关,即使它们是从地理上相距遥远的鸡群中分离出来的,也有共同的祖先。证据还表明,GA - 1、H - 30和CS - 2 - 35可能是减毒疫苗病毒的回复突变株,或者在遗传上偶然类似于经典的IBDV疫苗。应该注意的是,在分离出GA - 1、H - 30和CS - 2 - 35毒株时,一些经典病毒疫苗并未按照制造商的建议使用。综合分子和致病性数据表明,VP2中第253位的组氨酸(H)突变为谷氨酰胺(Q)或天冬酰胺(N)的单个氨基酸突变将显著增加减毒IBDV的毒力。